Rockefeller Capital Management
MED icon

Rockefeller Capital Management’s Medifast MED Stock Holding History

Rockefeller Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-376
Closed -$4.02K – 4814
2025
Q4 		$4.02K Buy
+376
New +$4.5K ﹤0.01% 4139
2023
Q1 		– Sell
-722
Closed -$83K – 3119
2022
Q4 		$83K Sell
722
-5
-0.7% -$582 ﹤0.01% 2123
2022
Q3 		$78K Buy
727
+716
+6,509% +$103K ﹤0.01% 2125
2022
Q2 		$1K Buy
+11
New +$1.97K ﹤0.01% 3978
2020
Q4 		– Sell
-164
Closed -$26K – 2951
2020
Q3 		$26K Buy
164
+61
+59% +$10K ﹤0.01% 1700
2020
Q2 		$14K Sell
103
-66
-39% -$6.06K ﹤0.01% 1791
2020
Q1 		$11K Buy
+169
New +$15.4K ﹤0.01% 1716

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Rockefeller Capital Management's MED Position: Q1 2026 in Review

Rockefeller Capital Management sold out of Medifast (MED) in Q1 2026, closing a stake of 376 shares — an estimated $4.02K sold.

Rockefeller Capital Management first reported a position in MED in Q1 2020 and held it in 7 quarters. The position peaked at $83K in Q4 2022. 112 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Rockefeller Capital Management reported no remaining Medifast position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 376 Medifast shares in Q1 2026, an estimated $4.02K.
  • Rockefeller Capital Management first reported a position in Medifast in Q1 2020 and held it in 7 quarters.
  • Rockefeller Capital Management's Medifast position peaked at $83K in Q4 2022.
  • 112 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.